Cannella, L. (2010) “Safety and efficacy of nilotinib in chronic phase chronic myeloid leukemia in a patient with Wolf-Parkinson-White disease and hematological resistance after suboptimal response to imatinib at six months”, Acta Oncologica, 49(3), pp. 399–400. doi: 10.3109/02841860903521129.